Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: Very High Risk Pathway

NHS to ensure people eligible for very high-risk breast screening are referred

Secondary breast cancer is an important risk factor after receiving radiotherapy for Hodgkin lymphoma

March 7, 2024 Breast Cancer, Hodgkin lymphoma, News, NHS England, Oncology, Very High Risk Pathway
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy